A Secure Online Service from Utah.gov

Utah.gov

Public Notice Website

Division of Archives and Records Service

State Medicaid DUR Board Meeting

Subscribe to Public Body

General Information

Government Type
State Agency
Entity
Department of Health and Human Services (DHHS)
Public Body
Drug Utilization Review Board

Notice Information

Add Notice to Calendar

Notice Title
State Medicaid DUR Board Meeting
Notice Type(s)
Meeting
Event Start Date & Time
December 11, 2025 07:15 AM
Event End Date & Time
December 11, 2025 08:30 AM
Event Deadline Date & Time
12/11/25 08:30 AM
Description/Agenda
Drug Utilization Review Board Meeting Agenda Thursday, December 11, 2025 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome and Introductions b) Review and Approval of Minutes 2) Prior Authorization Updates - Luis Moreno, PharmD 3) P&T Committee Update - Luis Moreno, PharmD 4) Public Comment 5) Review New Prior Authorization Criteria a) Opzelura (ruxolitinib cream) - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action b) Rinvoq, Rinvoq LQ (upadacitinib) - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action c) Tyenne (tocilizumab-aazg) and Biosimilars - Kyu Yun Park, PharmD i) Committee Discussion/Questions ii) Committee Action d) Xeljanz, Xeljanz XR (tofacitinib) - Kyu Yun Park, PharmD i) Committee Discussion/Questions ii) Committee Action e) Wegovy for the Treatment of MASH - Iris Wan, PharmD i) Committee Discussion/Questions ii) Committee Action f) Airsupra (albuterol and budesonide) - Skylar Fenton, PharmD i) Committee Discussion/Questions ii) Committee Action 6) Next Meeting a) Date: January 8, 2025 b) Topic: Combination Treatment with Botox and a Calcitonin Gene-Related Peptide Antagonist in the Setting of Chronic Migraine 7) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306#

Meeting Information

Meeting Location
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps
Contact Name
Luis Moreno
Contact Email
lmoreno@utah.gov
Contact Phone
801-538-6155

Notice Posting Details

Notice Posted On
November 28, 2025 04:44 PM
Notice Last Edited On
November 28, 2025 05:01 PM
Deadline Date
December 11, 2025 08:30 AM



Subscribe

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.